Metabolic Psychiatry in Practice: How Brain Fuels Flexibility, Mitochondrial Health, and Neuroinflammation Shapes Mood and Cognition Across the Lifespan

Background & Clinical Gap

Depression and cognitive decline are increasingly recognized as metabolic disorders of the brain, not just neurotransmitter imbalances. Yet most clinicians lack a practical framework to assess and target cerebral metabolism.

What This Session Delivers

You will leave with a clinically actionable model linking three convergent mechanisms:

• Brain insulin resistance (impaired glucose uptake, reduced synaptic plasticity)
• Mitochondrial dysfunction (low ATP, oxidative stress, poor mitophagy)
• Neuroinflammation (microglial activation driven by metabolic signals)

Key Clinical Insights

• Standard glucose metabolism is only half the story. The brain can run on ketones and lactate. Measuring fuel flexibility (fasting β-hydroxybutyrate, postprandial lactate) predicts treatment response better than any single neurotransmitter marker.
• β-hydroxybutyrate is not just fuel. At levels achievable with intermittent ketogenic protocols(0.5–1.5 mM), it reduces NLRP3 inflammasome activation, increases BDNF, and enhances mitochondrial biogenesis — effects independent of calorie restriction.
• Subtyping matters. Patients with high inflammatory-metabolic load (elevated hs-CRP, low T3, flat cortisol curve, insulin resistance) respond poorly to SSRIs alone but often improve dramatically with metabolic interventions.

Interventions You Can Implement (with biomarker guidance)

• Time-restricted feeding (14:10 or 16:8)Insulin sensitivity, circadian entrainment. Fasting insulin, HOMA-IR.
• Cyclic ketogenic protocol (5:2 or monthly 3-day) Fuel flexibility, BDNF, NLRP3. β-hydroxybutyrate, hs-CRP.
• Transcranial photobiomodulation (660/850 nm) Mitochondrial cytochrome c oxidase. Subjective cognition + optional EEG.
• Methylene blue (low dose, 0.5–1 mg/kg) Mitochondrial electron transport. No routine lab; monitor serotonin syndrome risk.
• Omega-3 EPA/DHA (≥2 g EPA) Neuroinflammation. Omega-3 index, hs-CRP.

Learning Objectives

• Assess brain fuel flexibility using available labs (insulin, β-hydroxybutyrate, lactate, hs-CRP, T3/rT3).
• Identify patients most likely to benefit from metabolic interventions vs. standard pharmacotherapy.
• Implement a stepped metabolic protocol starting with lifestyle (time-restricted eating, cyclic ketogenic) and escalating to adjunctive nutraceutical/photobiomodulation strategies.